Yes, I noted that too so really question the person's understanding of the drug development and approval process - no one is disagreeing that there is still a long road ahead. Bit of a pretty basic thing to get wrong in not knowing that Phase IV trials are post-approval real-world data collection studies used for monitoring and potentially exploring other indications.
Ann: Media release - First stroke patient with afamelanotide, page-14
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.55 |
Change
0.000(0.00%) |
Mkt cap ! $728.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 341 | $15.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.10 | 84 | 4 |
View Market Depth
| Last trade - 09.55am 10/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |
Day chart unavailable